Phase 4 study of dexmedetomidine for postoperative sedation in patients undergoing repair of thoracoabdominal aortic aneurysms.

Trial Profile

Phase 4 study of dexmedetomidine for postoperative sedation in patients undergoing repair of thoracoabdominal aortic aneurysms.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Postoperative pain; Sedation
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2009 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
    • 22 Sep 2009 Additional lead trial centre (Hospira, Inc.) identified as reported by ClinicalTrials.gov.
    • 28 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top